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Aim: We assessed the association of aortic valve sclerosis (AVS) with atherosclerotic risk
factors and severity and complexity of coronary artery disease (CAD).
Methods: In this retrospective study, a total of 482 eligible patients were divided into 2
groups: AVS present and AVS absent. All major cardiovascular risk factors and coronary
lesion characteristics were included.
Results: Age was the only independent predictor of AVS. AVS was not independently
associated with the number of obstructive vessels, degree of lesion obstruction and SYN-
TAX score.
Conclusion: AVS is probably a benign marker of age-related degenerative changes in the
heart independent of the severity and complexity of CAD.
Copyright © 2015, Cardiological Society of India. All rights reserved.1. Introduction
Being the site of frequent turbulence and mechanical stress
from blood flow, the aortic valve, serves as a focus for the
deposition of lipids involved in the process of atherosclerosis.1
Histopathologic studies of aortic valve sclerosis (AVS) show
accumulation of atherogenic lipoproteins, inflammatory cell
infiltrate, extra cellular matrix and microscopic
calcification.1e4 Several studies have linked AVS with
atherosclerotic risk factors, coronary and systemic athero-
sclerosis and cardiovascular morbidity, but the data is
conflicting.5e11
Increased prevalence of obstructive coronary lesions and
triple vessel coronary artery disease (CAD) has been shown in
patients with AVS, but the data are limited.12,13 Synergy0; fax: þ1 718 759 5807.
(H. Bhatt).
ociety of India. All rightsBetween Percutaneous Coronary InterventionWith Taxus and
Cardiac Surgery (SYNTAX) is an angiographic tool for grading
the complexity and severity of CAD and provides more
comprehensive assessment of coronary lesion characteris-
tics.14,15 We therefore aimed to determine the association of
presence or absence of AVS with cardiovascular risk factors,
extent of CAD and complexity and severity of coronary lesions
(using SYNTAX score).2. Methods
The protocol of this retrospective cohort study at a commu-
nity teaching hospital in Brooklyn, NY was approved by the
hospital's Institutional Review Board, and a waiver of patientreserved.
Table 1 e Baseline patient characteristics.
Risk factors Number e n (%)
482 patients
Hypertension 374 (77.6%)
Smoking 235 (48.7%)
Hypercholesterolemia 268 (55.6%)
eGFR (ml/min/1.73 m2)
90 203 (42.1%)
60e89 141 (29.2%)
30e59 95 (19.7%)
16e29 19 (3.9%)
15 24 (4.9%)
BMI (kg/m2)
<18.5 9 (1.8%)
18.5e25 130 (26.9%)
25.1e30 156 (32.3%)
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patients who underwent cardiac catheterization (CC) were
reviewed for the period of January 2010eDecember 2013.
Among these, the patients who underwent in-hospital trans-
thoracic echocardiograms (TTE) were selected. Data on de-
mographics, cardiovascular risk factors, medication use,
coronary lesion characteristics and SYNTAX score were
collected. Patients were divided into 2 groups based on the
presence or absence of AVS as stated in the TTE reports and
were compared based on aforementioned variables. Statistical
analysis was done using IBM SPSS Statistics 20. Univariate
analyses were carried out using the chi square test for cate-
gorical and ordinal variables, and ANOVA or t-test for
continuous variables. All risk factors with two-sided p < 0.05
on univariate analysis were put into a linear regressionmodel
to assess combined effects.30.1e35 103 (21.4%)
>35 84 (17.4%)
Diabetes mellitus 212 (43.9%)
Gender Male 298 (61.8%)
Female 184 (38.1%)
Age (years)
50 78 (16.2%)
51e70 234 (48.5%)
71 170 (35.2%)
Coronary artery disease 156 (32.3%)
Congestive heart failure 188 (39%)
Peripheral arterial disease 29 (6%)
CVA/TIA 37 (7.6%)
STEMI 52 (10.7%)
NSTEMI 110 (22.8%)
Unstable Angina 61 (12.6%)
Vessels with coronary artery disease
0 152 (31.5%)
1 113 (23.4%)
2 117 (24.2%)
3 100 (20.7%)
Lesion characteristics
Lesions with >70% stenosis in major
epicardial arteries
245 (50.8%)3. Results
Out of 708 patients, 482 patients were eligible: AVS present
(384 patients) and AVS absent (158 patients). Baseline patient
characteristics are summarized in Table 1.
Table 2 shows the presence or absence of AVS in patients
with major risk factors, comorbidities and lesion character-
istics, and displays the findings of univariate analyses.
Subsequently, multivariable linear regression analyses
were carried out to determine independent associations. All
significant factors from univariate analysis, gender and SYN-
TAX score were included in the model. Only age (p ¼ 0.001, b
1.11) was found to be independently associated with the
presence of AVS. The presence of AVSwas not associatedwith
number of obstructive vessels (p ¼ 0.831, b 0.01), lesions with
>70% stenosis in major (p ¼ 0.849, b 0.95) andminor (p¼ 0.100,
b 1.59) epicardial arteries, lesions with 50e70% stenosis in
major (p¼ 0.267, b 1.38) andminor (p¼ 0.237, b 0.73) epicardial
arteries or SYNTAX score (p ¼ 0.684, b 0.02).Lesions with >70% stenosis in minor
epicardial arteries
147 (30.5%)
Lesions with 50e70% stenosis in major
epicardial arteries
138 (28.6%)
Lesions with 50e70% stenosis in minor
epicardial arteries
79 (16.4%)
Lesions with less than 50% stenosis in
epicardial arteries
304 (63.1%)
Arteries with diffuse disease 252 (52.3%)
Calcified lesions 83 (17.3%)
Bifurcation Lesions 43 (8.9%)
Mean SYNTAX score 325 (67.4%)
Statin 235 (48.7%)
Beta-blocker 257 (53.3%)
ACE-I/ARB 199 (41.3%)
Calcium channel blocker 99 (20.5%)
Aspirin 261 (54.1%)
AVS ¼ Aortic Valve Sclerosis, eGFR ¼ Estimated Glomerular Filtra-
tion Rate, BMI ¼ Body Mass Index, CVA/TIA ¼ Cerebrovascular
Event/Transient Ischemic Attack, NSTEMI ¼ Non ST Elevation
Myocardial Infarction, STEMI ¼ ST Elevation Myocardial Infarction,
SYNTAX ¼ Synergy between Percutaneous Coronary Intervention
with Taxus and Cardiac Surgery, ACE-I/ARB ¼ Angiotensin Con-
verting Enzyme Inhibitor/Angiotensin Receptor Blocker.4. Discussion
In our study, age was independently associated with the
presence of AVS. Other major cardiovascular risk factors,
number of obstructive vessels, coronary lesion characteristics
and SYNTAX score were not independently associated with
AVS.
Our study demonstrates an increase in the prevalence of
AVS with aging, especially in patients 71 years old. AVS has
been consistently linked with age and is considered a marker
of senile degenerative changes resulting from hemodynamic
stress in heart.2,10,13,14 In our study, increased prevalence of
AVS was noted after age 50 years, which has not been
commonly shown in the literature. Whereas, none of the
other cardiovascular risk factors shown in Table 2 were
associated with AVS.
In a study of 160 patients, Soydinc et al found that AVS was
associated with the presence of triple vessel CAD and was
independently associated with Gensini score.13 A study of 230
patients from Fazlinezhad et al found AVS to be an indepen-
dent predictor of obstructive coronary disease (i.e., 50%
Table 2 e Univariate analysis by presence or absence of AVS.
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as a cardiovascular risk factor in their analyses. In addition,
these studies only assessed lesions in major epicardial coro-
nary arteries such as left main, left circumflex, left anterior
descending and right main. In our study, AVS was not inde-
pendently associated with number of obstructive vessels, le-
sions with different degrees of obstruction in both major and
minor epicardial arteries and mean SYNTAX score. Besides
having a greater sample size, our study provided a compre-
hensive assessment of cardiovascular risk factors and coro-
nary lesions in both major and smaller coronary arteries
visualized on coronary angiography. In addition, the associa-
tion between AVS and SYNTAX score has not been previously
investigated. These findings suggest that AVS should not be
used in isolation from cardiovascular risk factors as a nonin-
vasive indicator of coronary atherosclerosis, and its use as a
marker for severe obstructive CAD remains a topic of debate.
The retrospective nature of this study meant that patient
data were obtained from chart review. Counteracting this
limitation is the consistency with which TTE and CC reports
are documented in our institution, which lends credibility to
these findings. The interpretation of TTE reports was not
limited to a few selected cardiologists, and thus our results
may have inter-observer variability. However, if this vari-
ability was present, we expect that it was minimal, because
we classified AVS based on visual presence or absence,
without grading the severity of sclerosis. Angiographic inter-
pretation of coronary lesion characteristics and SYNTAX score
(using an algorithm) was limited to an experienced interven-
tional cardiologist, which eliminates the inter-observer
variability.In conclusion, our study demonstrates that AVS acts as a
marker of senile degenerative changes in the heart. Increased
prevalence of AVS in patients with CV risk factors such as
hypertension, DM and hypercholesterolemia, as commonly
shown in the literature, is probably related to aging. Our study
suggests that AVS may not be a precise echocardiographic
marker of obstructive CAD and SYNTAX score. Given previous
studies, AVS may be associated with systemic atherosclerosis
and CV events, but its utility in predicting the complexity and
severity of coronary lesions remains questionable.Conflicts of interest
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